Temporal stability of eight phthalate metabolites and their glucuronide conjugates in human urine

Environmental Research

Volumn 109, Issue 5, 2009, Pages 641-646

  Samandar, Ella ^a   Silva, Manori J ^a   Reidy, John A ^a   Needham, Larry L ^a   Calafat, Antonia M ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

Biomonitoring; Exposure; Glucuronidation; Phthalate metabolites; Phthalate stability

Indexed keywords

BIOACTIVITY; BIOMONITORING; CONCENTRATION (COMPOSITION); MEASUREMENT METHOD; METABOLITE; PHTHALATE; QUANTITATIVE ANALYSIS; URINE;

ENVIRONMENTAL EXPOSURE; GLUCURONIDES; HUMANS; PHTHALIC ACIDS;

EID: 67349107126     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2009.02.004     Document Type: Review

References (21)

1. Albro P.W., Tondeur I., Marbury D., Jordan S., Schroeder J., and Corbett J.T. Polar metabolites of di-(2-ethylhexyl)phthalate in the rat. Biochim. Biophys. Acta 760 (1983) 283-292
2. Brock J.W., Caudill S.P., Silva M.J., Needham L.L., and Hilborn E.D. Phthalate monoesters levels in the urine of young children. Bull. Environ. Contam. Toxicol. 68 (2002) 309-314
3. Calafat A.M., Needham L.L., Silva M.J., and Lambert G. Exposure to di-(2-ethylhexyl) phthalate among premature neonates in a neonatal intensive care unit. Pediatrics 113 (2004) e429-e434
4. Calafat A.M., Silva M.J., Reidy J.A., Gray L.E., Samandar E., Preau J.L., Herbert A.R., and Needham L.L. Mono-(3-carboxypropyl) phthalate, a metabolite of di-n-octyl phthalate. J. Toxicol. Environ. Health A 69 (2006) 215-227
5. David, R.M., McKee, R.H., Butala, J.H., Barter, R.A., Kayser, M., 2001. Esters of aromatic mono-, di-, and tricarboxylic acids, aromatic diacids, and di-, tri-, or polyalcohols. In: Bingham, E., Cohrssen, B., Powell, C.H. (Eds.), Patty's Toxicology, vol. 6, fifth ed. Wiley, New York, pp. 635-932.
6. Duty S.M., Silva M.J., Barr D.B., Brock J.W., Ryan L., Chen Z.Y., Herrick R.F., Christiani D.C., and Hauser R. Phthalate exposure and human semen parameters. Epidemiology 14 (2003) 269-277
7. Hauser R., Meeker J.D., Duty S., Silva M.J., and Calafat A.M. Altered semen quality in relation to urinary concentrations of phthalate monoester and oxidative metabolites. Epidemiology 17 (2006) 682-691
8. Hoppin J.A., Ulmer R., Calafat A.M., Barr D.B., Baker S.V., Meltzer H.M., and Ronningen K.S. Impact of urine preservation methods and duration of storage on measured levels of environmental contaminants. J. Exp. Sci. Environ. Epidemiol. 16 (2006) 39-48
9. Kato K., Silva M.J., Needham L.L., and Calafat A.M. Determination of 16 phthalate metabolites in urine using automated sample preparation and on-line preconcentration/high-performance liquid chromatography/tandem mass spectrometry. Anal. Chem. 77 (2005) 2985-2991
10. Kato K., Silva M.J., Reidy J.A., Hurtz D., Malek N.A., Needham L.L., Nakazawa H., Barr D.B., and Calafat A.M. Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. Environ. Health Perspect. 112 (2004) 327-330
11. Koch H.M., Drexler H., and Angerer J. Internal exposure of nursery-school children and their parents and teachers to di(2-ethylhexyl)phthalate (DEHP). Int. J. Hyg. Environ. Health 207 (2004) 15-22
12. Koch H.M., Muller J., Drexler H., and Angerer J. Dibutylphthalate (DBP) in medications: are pregnant women and infants at risk?. Umweltmed. Forsch. Prax. 10 (2005) 144-146
13. National Children's Study. National children's study. Available: 〈http://www.nationalchildrensstudy.gov/〉 (accessed 04.06.2008).
14. Silva M.J., Barr D.B., Reidy J.A., Kato K., Malek N.A., Hodge C.C., Hurtz D., Calafat A.M., Needham L.L., and Brock J.W. Glucuronidation patterns of common urinary and serum monoester phthalate metabolites. Arch. Toxicol. 77 (2003) 561-567
15. Silva M.J., Barr D.B., Reidy J.A., Malek N.A., Hodge C.C., Caudill S.P., Brock J.W., Needham L.L., and Calafat A.M. Urinary levels of seven phthalate metabolites in the US population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ. Health Perspect. 112 (2004) 331-338
16. Silva M.J., Preau J.L., Needham L.L., and Calafat A.M. Cross validation and ruggedness testing of analytical methods for the quantification of urinary phthalate metabolites. J. Chromatogr. B 873 (2008) 180-186
17. Silva M.J., Reidy J.A., Preau J.L., Needham L.L., and Calafat A.M. Oxidative metabolites of diisononyl phthalate as biomarkers for human exposure assessment. Environ. Health Perspect. 114 (2006) 1158-1161
18. Silva M.J., Samandar E., Preau J.L., Needham L.L., and Calafat A.M. Urinary oxidative metabolites of di(2-ethylhexyl) phthalate in humans. Toxicology 219 (2006) 22-32
19. Silva M.J., Samandar E., Preau J.L., Reidy J.A., Needham L.L., and Calafat A.M. Quantification of 22 phthalate metabolites in human urine. J. Chromatogr. B 860 (2007) 106-112
20. Silva M.J., Samandar E., Reidy J.A., Hauser R., Needham L.L., and Calafat A.M. Metabolite profiles of di-n-butyl phthalate in humans and rats. Environ. Sci. Technol. 41 (2007) 7576-7580
21. Swan S.H., Main K.M., Liu F., Stewart S.L., Kruse R.L., Calafat A.M., Mao C.S., Redmon J.B., Ternand C.L., Sullivan S., and Teague J.L. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ. Health Perspect. 113 (2005) 1056-1061